BioSpace News Archive

The anatomic pathology market worldwide is experiencing stiff competition because of the presence of numerous large companies and a handful of regional players challenging their might in the local pockets.

The OPTI-STEM project aims to optimize the production of MSCs in order to democratize access to them and thus allow the diversification of therapeutic applications of this type of cells and their derivatives.

Medivir AB announces that an article entitled “Symptomatic and structural benefit of cathepsin K inhibition by MIV-711 in a subgroup with unilateral pain: post-hoc analysis of a randomised phase 2a clinical trial” by Bihlet, A.R. et al has been published in Clinical and Experimental Rheumatology 2022.

Evelo Biosciences, Inc., a clinical stage biotechnology company developing SINTAX™ medicines as a new modality of orally delivered treatments for inflammatory disease, announced data from the post-treatment follow-up of its Phase 2 trial of EDP1815 in mild and moderate psoriasis which included durable and deeper clinical responses.

Crinetics Pharmaceuticals, Inc. and Sanwa Kagaku Kenkyusho Co., Ltd. announced that the parties have entered into a strategic partnership to exclusively develop and commercialize paltusotine in Japan.

DENTSPLY SIRONA Inc. announced its financial results for the fourth quarter and full year 2021.

Exact Sciences Corp., a leader in advanced cancer diagnostics, announced that company management will participate in the following conferences and invited investors to participate by webcast.

Cincinnati-based Standard Bariatrics, Inc., an emerging leader in the bariatric surgery medical device field, announced completion of a $35 million Series B round ahead of schedule.

Aurinia Pharmaceuticals Inc. issued its financial results for the fourth quarter and year ended December 31, 2021.

MediciNova, Inc. and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that MN-166 (ibudilast) was discussed as a potential beneficial pharmacological agent for the treatment of degenerative cervical myelopathy (DCM) in Global Spine Journal.